PG
ATRC icon

PEAK6 Group’s AtriCure ATRC Stock Holding History

PEAK6 Group’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,789
Closed -$30K – 4271
2016
Q1 		$30K Buy
+1,789
New +$31.5K ﹤0.01% 4025
2013
Q3 		– Sell
-3,600
Closed -$34 – 5063
2013
Q2 		$34 Buy
+3,600
New +$31.4K ﹤0.01% 4558

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

PEAK6 Group's ATRC Position: Q2 2016 in Review

PEAK6 Group sold out of AtriCure (ATRC) in Q2 2016, closing a stake of 1,789 shares — an estimated $30K sold.

PEAK6 Group first reported a position in ATRC in Q2 2013 and held it in 2 quarters. The position peaked at $30K in Q1 2016. 102 funds tracked by Wall St. Rank hold ATRC as of Q2 2016.

  • PEAK6 Group reported no remaining AtriCure position as of Q2 2016 after selling out during the quarter.
  • PEAK6 Group sold 1,789 AtriCure shares in Q2 2016, an estimated $30K.
  • PEAK6 Group first reported a position in AtriCure in Q2 2013 and held it in 2 quarters.
  • PEAK6 Group's AtriCure position peaked at $30K in Q1 2016.
  • 102 funds tracked by Wall St. Rank held AtriCure as of Q2 2016.

Based on PEAK6 Group's 13F filing for Q2 2016, filed 10 Aug 2016.